Armistice Capital, LLC, Director, 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 11,400,000 shares at $2.26 ($25.1M) on 2021-09-15, disclosed to the SEC on 2021-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 95,455 | $216K | 0.9% |
| 2 | $2.26 | 95,455 | $216K | 0.9% |
| 3 | $2.28 | 150,000 | $342K | 1.4% |
| 4 | $2.28 | 150,000 | $342K | 1.4% |
| 5 | $2.20 | 5,454,545 | $12.0M | 47.8% |
| 6 | $2.20 | 5,454,545 |
| $12.0M |
| 47.8% |
| Total | $2.20 avg | 11,400,000 | $25.1M | 100% |
| Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |
| CERC | BUY | 2021-05-18 | $392K | — | Filing → |